| Product NDC: | 0378-2250 |
| Proprietary Name: | Mycophenolate Mofetil |
| Non Proprietary Name: | mycophenolate mofetil |
| Active Ingredient(s): | 250 mg/1 & nbsp; mycophenolate mofetil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-2250 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065520 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120904 |
| Package NDC: | 0378-2250-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2250-01) |
| NDC Code | 0378-2250-01 |
| Proprietary Name | Mycophenolate Mofetil |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2250-01) |
| Product NDC | 0378-2250 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mycophenolate mofetil |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120904 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | MYCOPHENOLATE MOFETIL |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |